ATEX.NASDAQAnterix INC

Form 4: Anterix Inc. COO Ryan Gerbrandt Acquires Stock Options

Sentiment:

SEC Form 4 Filing


Ryan Gerbrandt, Chief Operating Officer of Anterix Inc., reports the acquisition of stock options.

Summary

  • Ryan Gerbrandt, the Chief Operating Officer of Anterix Inc., filed a Form 4.
  • The filing reports the acquisition of 53,491 stock options with an exercise price of $34.96 on May 20, 2025.
  • The options vest in three equal annual installments starting May 20, 2026, and expiring on May 20, 2035.

Sentiment

Score: 6

Explanation: Neutral sentiment. The document simply reports a transaction. The granting of stock options is generally viewed as a positive incentive, but the document itself is purely informational.

Positives

  • The acquisition of stock options by a key executive can be seen as a positive sign, aligning their interests with the company's success.

Industry Context

Stock option grants are a common form of executive compensation in the technology and telecommunications industries, used to incentivize performance and align executive interests with shareholder value.

Comparison to Industry Standards

  • Stock option grants are a standard component of executive compensation packages in publicly traded companies, particularly in growth-oriented sectors like telecommunications.
  • The size of the grant (53,491 options) would need to be compared to grants given to executives in comparable roles at similar-sized companies in the telecommunications industry to assess its relative magnitude.
  • Companies like Verizon, AT&T, and T-Mobile also use stock options as part of their executive compensation, but the specific terms and amounts vary based on company performance, executive level, and other factors.

Stakeholder Impact

  • The granting of stock options could potentially incentivize the COO to improve company performance, benefiting shareholders.
  • Employees may view the grant as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
05/20/2025Date of earliest transaction (grant date of stock options)
05/20/2026First vesting date for 1/3 of the stock options
05/20/2035Expiration date of the stock options
05/22/2025Date of Form 4 filing

Keywords

Form 4, stock options, Ryan Gerbrandt, Anterix Inc., ATEX, COO, acquisition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.